We recently found that the expression of antioxidant genes (i.g. SLC7A11, GCLM, NQO1) was significantly upregulated in cells treated by iron oxide nanoparticles [27], we therefore deduced that the activated antioxidation system in cells should weaken the anti-tumor effect of GIFT. Here, SLC7A11 is linked to neoplasm.